• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Testing should not be done in all patients treated with clopidogrel who are undergoing percutaneous coronary intervention.

作者信息

Paré Guillaume, Eikelboom John W, Sibbing Dirk, Bernlochner Isabell, Kastrati Adnan

机构信息

Population Health Research Institute, Hamilton General Hospital, 237 Barton St East, Hamilton, Ontario, Canada.

出版信息

Circ Cardiovasc Interv. 2011 Oct 1;4(5):514-21; discussion 521. doi: 10.1161/CIRCINTERVENTIONS.111.962142.

DOI:10.1161/CIRCINTERVENTIONS.111.962142
PMID:22010190
Abstract
摘要

相似文献

1
Testing should not be done in all patients treated with clopidogrel who are undergoing percutaneous coronary intervention.对于所有接受氯吡格雷治疗且正在接受经皮冠状动脉介入治疗的患者，不应进行检测。
Circ Cardiovasc Interv. 2011 Oct 1;4(5):514-21; discussion 521. doi: 10.1161/CIRCINTERVENTIONS.111.962142.
2
Current evidence for genetic testing in clopidogrel-treated patients undergoing coronary stenting.氯吡格雷治疗的冠状动脉支架置入患者基因检测的现有证据。
Circ Cardiovasc Interv. 2011 Oct 1;4(5):505-13; discussion 513. doi: 10.1161/CIRCINTERVENTIONS.111.962183.
3
CYP2C19 but not PON1 genetic variants influence clopidogrel pharmacokinetics, pharmacodynamics, and clinical efficacy in post-myocardial infarction patients.CYP2C19 而非 PON1 基因变异影响心肌梗死后患者氯吡格雷的药代动力学、药效学和临床疗效。
Circ Cardiovasc Interv. 2011 Oct 1;4(5):422-8. doi: 10.1161/CIRCINTERVENTIONS.111.963025. Epub 2011 Oct 4.
4
Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement.细胞色素 2C19*17 等位基因变异、血小板聚集、出血事件和氯吡格雷治疗的冠状动脉支架置入患者的支架血栓形成。
Circulation. 2010 Feb 2;121(4):512-8. doi: 10.1161/CIRCULATIONAHA.109.885194. Epub 2010 Jan 18.
5
Impact of CYP2C19 genetic testing on provider prescribing patterns for antiplatelet therapy after acute coronary syndromes and percutaneous coronary intervention.CYP2C19基因检测对急性冠状动脉综合征和经皮冠状动脉介入治疗后抗血小板治疗的医生处方模式的影响。
Circ Cardiovasc Qual Outcomes. 2013 Nov;6(6):694-9. doi: 10.1161/CIRCOUTCOMES.113.000321. Epub 2013 Nov 5.
6
Translational platelet research in patients with coronary artery disease: what are the major knowledge gaps?翻译：冠心病患者的转化性血小板研究：主要存在哪些知识空白？
Thromb Haemost. 2012 Jul;108(1):12-20. doi: 10.1160/TH12-01-0039. Epub 2012 May 25.
7
Standard- vs high-dose clopidogrel after percutaneous coronary intervention.经皮冠状动脉介入治疗后标准剂量与高剂量氯吡格雷的比较
JAMA. 2011 Jun 22;305(24):2520; author reply 2521-2. doi: 10.1001/jama.2011.842.
8
Carriage of reduced-function CYP2C19 allele among patients treated with clopidogrel.接受氯吡格雷治疗患者中携带功能降低的CYP2C19等位基因的情况。
JAMA. 2011 Feb 2;305(5):467-8; author reply 468. doi: 10.1001/jama.2011.77.
9
Differential impacts of CYP2C19 gene polymorphisms on the antiplatelet effects of clopidogrel and ticlopidine.CYP2C19 基因多态性对氯吡格雷和噻氯匹定抗血小板作用的影响差异。
Clin Pharmacol Ther. 2011 Feb;89(2):229-33. doi: 10.1038/clpt.2010.268. Epub 2010 Dec 22.
10
Genetic determinants of on-clopidogrel high platelet reactivity.氯吡格雷抵抗的遗传决定因素。
Platelets. 2011;22(6):399-407. doi: 10.3109/09537104.2011.579648. Epub 2011 May 31.

引用本文的文献

1
Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.药物遗传学在公共卫生与临床医疗保健中的作用：一项SWOT分析。
Eur J Hum Genet. 2016 Dec;24(12):1651-1657. doi: 10.1038/ejhg.2016.114. Epub 2016 Aug 31.
2
High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel.接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者的高血小板反应性：比较普拉格雷和氯吡格雷的随机对照试验
PLoS One. 2015 Aug 28;10(8):e0135037. doi: 10.1371/journal.pone.0135037. eCollection 2015.
3
Genetic profiles in ischaemic stroke.
缺血性脑卒中的基因谱。
Curr Atheroscler Rep. 2013 Aug;15(8):342. doi: 10.1007/s11883-013-0342-8.
4
Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?氯吡格雷和华法林药物遗传学检测：在临床实践中应用的证据是什么？
Curr Opin Cardiol. 2013 May;28(3):305-14. doi: 10.1097/HCO.0b013e32835f0bbc.
5
Stroke genetics: prospects for personalized medicine.中风遗传学：个性化医疗的前景。
BMC Med. 2012 Sep 27;10:113. doi: 10.1186/1741-7015-10-113.